405 related articles for article (PubMed ID: 15044356)
1. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.
Brubaker PL; Drucker DJ
Endocrinology; 2004 Jun; 145(6):2653-9. PubMed ID: 15044356
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
Drucker DJ
Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
[TBL] [Abstract][Full Text] [Related]
3. Minireview: the glucagon-like peptides.
Drucker DJ
Endocrinology; 2001 Feb; 142(2):521-7. PubMed ID: 11159819
[TBL] [Abstract][Full Text] [Related]
4. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
Baggio LL; Drucker DJ
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
[TBL] [Abstract][Full Text] [Related]
6. Gut adaptation and the glucagon-like peptides.
Drucker DJ
Gut; 2002 Mar; 50(3):428-35. PubMed ID: 11839727
[TBL] [Abstract][Full Text] [Related]
7. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 2.
Drucker DJ
J Clin Endocrinol Metab; 2001 Apr; 86(4):1759-64. PubMed ID: 11297614
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling.
Estall JL; Drucker DJ
J Nutr; 2003 Nov; 133(11):3708-11. PubMed ID: 14608100
[TBL] [Abstract][Full Text] [Related]
10. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
Otto Buczkowska E; Dworzecki T
Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets.
Burrin DG; Stoll B; Guan X; Cui L; Chang X; Holst JJ
Endocrinology; 2005 Jan; 146(1):22-32. PubMed ID: 15486229
[TBL] [Abstract][Full Text] [Related]
12. Biological actions and therapeutic potential of the glucagon-like peptides.
Drucker DJ
Gastroenterology; 2002 Feb; 122(2):531-44. PubMed ID: 11832466
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 and extra-islet effects.
Ahrén B
Horm Metab Res; 2004; 36(11-12):842-5. PubMed ID: 15655717
[TBL] [Abstract][Full Text] [Related]
14. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.
Li Y; Cao X; Li LX; Brubaker PL; Edlund H; Drucker DJ
Diabetes; 2005 Feb; 54(2):482-91. PubMed ID: 15677506
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.
List JF; Habener JF
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E875-81. PubMed ID: 15140754
[TBL] [Abstract][Full Text] [Related]
16. The role of GLP-1 in the life and death of pancreatic beta cells.
Perfetti R; Hui H
Horm Metab Res; 2004; 36(11-12):804-10. PubMed ID: 15655712
[TBL] [Abstract][Full Text] [Related]
17. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
Egan JM; Bulotta A; Hui H; Perfetti R
Diabetes Metab Res Rev; 2003; 19(2):115-23. PubMed ID: 12673779
[TBL] [Abstract][Full Text] [Related]
19. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
20. Biologic actions and therapeutic potential of the proglucagon-derived peptides.
Drucker DJ
Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):22-31. PubMed ID: 16929363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
